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Abbreviations: 
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L-NAME: Nw-Nitro-L-Arginine Methyl Ester 
NO: nitric oxide 
TGF-β: transforming growth factor beta 
TPA: 12-O-tetradecanoylphorbol-13-acetate 
VEGF: vascular endothelial growth factor  
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Abstract 
 
Endoglin is a transmembrane glycoprotein mainly expressed in endothelial cells but 
it is also present in the epidermis and skin appendages. To address the role of endoglin in 
cutaneous wound healing, we compared the kinetics of re-epithelialization of endoglin 
heterozygous null (Eng+/–) mice and their normal littermates (Eng+/+) after skin wounds. In 
Eng+/+ mice wound closure was complete after 12 days, whereas in Eng+/- mice closure 
occurred 1 or 2 days later, the biggest differences being observed 4-6 days after wounding. 
In Eng+/- mice keratinocytes at the wound edges exhibited impaired proliferation but were 
more migratory, as shown by their elongated morphology and increased keratin 17 
expression. Liposomal delivery of endoglin cDNA to the wounds significantly accelerated 
the rate of healing in Eng+/- mice, without significantly effect in Eng+/+ mice. Inhibition of 
nitric oxide (NO) synthesis delayed healing in Eng+/+ but not in Eng+/- mice. 
Administration of the NO donor LA-803 accelerated wound closure in Eng+/- mice with no 
effect in normal littermates. The skin of Eng+/- mice failed to mount a hyperplastic response 
to acute stimulation with 12-O-tetradecanoylphorbol-13-acetate. These results demonstrate 
an important involvement of endoglin in wound healing that seems to be related with NO 
availability. 
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INTRODUCTION 
 
Physiological wound healing is a highly organized process in which tight temporal 
and spatial coordination of various events and signaling networks is essential (Grose and 
Werner, 2004; Gurtner et al., 2008; Martin, 1997). Cutaneous wound healing begins 
immediately after a skin injury in an attempt to provide a protective barrier against further 
external stimulations or infections. Proper skin wound repair requires the coordinated 
activation of different cell and tissue responses, including re-epithelialization, connective 
tissue contraction and angiogenesis, the latter process leading to the formation of a dense 
network of blood vessels in the wound granulation tissue. A robust inflammatory response 
commencing soon after tissue damage, followed by tissue remodeling, are also important 
steps in tissue repairing (Martin, 1997). The wound healing process is interactive and 
dynamic, involving multiple soluble mediators, extracellular matrix, blood cells, 
keratinocytes and parenchymal cells (Coulombe, 2003). Delayed skin wound healing is a 
serious complication in diabetes and is caused primarily by microangiopathy and impaired 
cutaneous blood flow, hypoxia, accelerated inflammation, edema, and endothelial 
dysfunction (Martin et al., 2003; Reiber et al., 1999). Moreover, expression of vascular 
endothelial growth factor (VEGF)-A is markedly reduced in wounds of diabetic patients 
(Frank et al., 1995; Kampfer et al., 2001).  
The genetic control of wound healing involves multiple families of growth factors, 
of which transforming growth factor-β (TGF-β) is a classic example (Singer and Clark, 
1999). TGF-β expression is present throughout wound healing and regulates many 
processes involved in tissue repair (Valluru et al., 2011a). Endoglin (CD105) is a 180 kDa 
homodimeric transmembrane glycoprotein that modulates cellular responses to ligands of 
the TGF- superfamily (Gougos and Letarte, 1990; Barbara et al., 1999; Li et al., 2000; 
López-Novoa and Bernabeu, 2010). Endoglin is up-regulated in tissues undergoing 
angiogenesis (Jerkic et al., 2006a; Fonsatti et al., 2003; López-Novoa and Bernabeu, 2010) 
and inhibition of its expression in endothelial cells impairs this process (Li et al., 2000). 
Endoglin null mice die at mid-gestation from defective angiogenesis and severe 
cardiovascular abnormalities, while Endoglin heterozygous (Eng+/) mice have a normal 
life span (Li et al., 1999; Bourdeau et al., 1999; Arthur et al., 2000). Endoglin has been 
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shown to regulate vascular function through modulation of endothelial nitric oxide synthase 
(eNOS) expression and activity (Jerkic et al., 2004; Toporsian et al., 2005; Jerkic et al., 
2006a), and seems to play a major role in the regulation of angiogenesis (Jerkic et al., 
2006b; Lebrin and Mummery, 2008). Endoglin is also expressed in keratinocytes of the 
interfollicular epidermis and hair bulbs where it acts to attenuate TGF- signaling 
(Quintanilla et al., 2003; Pérez-Gómez et al., 2007). Endoglin expression increases after 
dermal wound in association with inflammation (Torsney et al., 2002). In addition, 
endoglin is overexpressed in some skin diseases such as scleroderma or psoriasis (Maring 
et al., 2012; Rulo et al., 1995). The purpose of this study was to assess the role of endoglin 
in epidermal re-epithelialization by studying the effect of endoglin insufficiency on 
cutaneous healing after an excisional wound.  
 
RESULTS 
 
Temporal and spatial expression of endoglin during repair 
We first analyzed endoglin expression during wound healing in normal mice (Suppl. 
Fig. 1). Endoglin expression was low in control skin (day 0) but gradually increased after 
wounding reaching maximal values 4 days after the injury and decreasing by 8 days (Suppl. 
Fig. 1A). Next, we determined the localization of endoglin expression in the wounded area 
by immunohistochemical analysis. Basal-like keratinocytes at the wound edges and blood 
vessels of the sub-epithelial area were the main cellular sources of endoglin protein (Suppl. 
Fig. 1B).  
 
Delayed wound closure in endoglin-deficient mice 
We introduced full-thickness wounds into the dorsal skin of Eng+/+ and Eng+/– mice 
and analyzed wound closure 2-14 days after the injury, as indicated in Materials and 
Methods. Eng+/– mice exhibited delayed wound closure compared with Eng+/+ mice (Fig. 
1). In Eng+/+ mice, wound closure was complete on day 12, whereas in Eng+/– animals this 
occurred 1 or 2 days later. The most important differences between the two genotypes were 
observed promptly after the injury. For instance, 4 days after wounding, about 60% wound 
closure was observed in Eng+/+ mice, compared to 40% in Eng+/- mice. The rate of healing, 
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expressed as the half closing time (HCT), was 3.2 ± 0.2 days in Eng+/+ and 4.2 ± 0.2 days 
in Eng+/– mice (Fig. 1D). To further assess the role of endoglin in wound healing, a plasmid 
containing the human endoglin cDNA (ENG) in a liposome preparation was applied into 
the wounds. ENG application accelerated healing in Eng+/– mice and did not affect wound 
closure in Eng+/+ mice (Fig. 1A). In contrast, the application of liposomes containing the 
empty vector had no effect in either Eng+/+ or Eng+/– mice (data not shown). HCT was 
clearly reduced in Eng+/– mice treated with ENG with respect to untreated animals (from 
4.2 ± 0.2 to 3.3 ± 0.2 days), while it did not change in untreated and treated wild-type mice 
(3.2 ± 0.2 and 3.3 ± 0.2 days, respectively).  
Oral administration of the NOS inhibitor L-NAME significantly delayed wound 
healing in Eng+/+ mice, but the effect was minimal in Eng+/– mice (Fig. 2B, D). In contrast, 
administration of the NO donor LA-803 accelerated the rate of healing in Eng+/– mice with 
almost no effect in Eng+/+ mice (Fig. 1C, D). These results suggest that reduced NO levels 
plays a crucial role in the delayed wound healing observed in Eng+/– mice. 
 Histological examination of the wounds revealed that 4 days after the injury the 
hyperproliferative epithelium at the wound edges was thinner in Eng+/- with respect to 
Eng+/+ mice (Fig. 2A, B). However, keratinocytes forming the new epithelium in Eng+/- 
wounds exhibited a more elongated morphology than those of normal mice (see below). 
The difference in thickness of the regenerated epidermis between Eng+/+ and Eng+/- mice 
was also evident at 12 days after the injury when wounds are completely re-epithelialized 
(Figure 2C, D). Thus, the regenerated epithelium in Eng+/- mice was formed by only 1-2 
layers (Fig. 2D) in clear contrast with 3-6 layers in the new epidermis of Eng+/+ mice (Fig. 
2C). On the other hand, 4 days after wounding, the granulation tissue was visible at the 
edges and base of Eng+/+ wounds, whereas it was localized at the edges but did not extend 
to the base of the wounds in Eng+/- mice (Fig. 2A, B). This result indicates that formation 
of granulation tissue was delayed in mutant mice. Similarly, 6 days after the injury, both re-
epithelialization and granulation tissue formation appeared less elaborate in Eng+/- in 
comparison with wild type mice (data not shown).  
 
Disturbed epidermal proliferation in endoglin-deficient mice 
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In order to determine the proportion of proliferating keratinocytes in the 
regenerating epithelium of normal and mutant mice, we performed Ki67 staining in the 
epidermis adjacent to the wounds. In unwounded areas, no evident differences in basal 
epidermal cell proliferation were observed between Eng+/+ and Eng+/- (Fig. 3A, B). 
Nevertheless, in wounded areas, a clear reduction of Ki67-positive keratinocytes was 
observed in mutant with respect to normal mice (as shown in Fig. 3C, D for wounds 6 days 
after the injury). Even at 12 days post-wounding, proliferation was still observed in the 
basal layer of the regenerated epidermis of Eng+/+ mice (Fig. 3E), whereas only faint Ki67 
staining was seen in the new epithelium of Eng+/– mice (Fig. 3F). As shown in Fig. 2, 
keratinocytes in the new-covered areas show a more elongated shape in  Eng+/–  than in 
Eng+/+ mice (Fig. 3D and F). These results, together with the histological analysis 
presented in Fig. 2, suggest that activation of keratinocyte proliferation following to 
cutaneous injury is defective in endoglin-deficient animals.  
Keratin 17 (K17) is expressed by activated suprabasal keratinocytes migrating onto 
the wound bed (Patel et al., 2006). Immunofluorescence staining of K17 in wounds at 6 
days after the injury revealed that both the number of K17-positive cells and the intensity of 
staining were increased in Eng+/- (Suppl. Fig. 2C, D) with respect to Eng+/+ (Suppl. Fig. 
2A, B) mice, suggesting that the epidermis of Eng+/- mice adjacent to the wound, whereas 
unable to accumulate proliferating cells, contained a higher number of migratory 
keratinocytes compared to the epidermis of normal mice. 
In order to analyze further the relationship between epidermal proliferation and 
endoglin, the skin of normal and mutant mice was subjected to an acute proliferative 
stimulus with the tumor promoter TPA. Skin sections were taken 24 h and 48 h after the 
application of either TPA or vehicle (acetone) and endoglin expression analyzed by real-
time qRT-PCR and Western blotting. TPA significantly increased endoglin levels in both 
Eng+/+ and Eng+/- mice, although the increase was lower in endoglin-deficient animals (Fig. 
4A, B). Endoglin expression in the interfollicular epidermis of TPA-stimulated normal 
mice was restricted to the basal-like layer and associated with hyperproliferation, as found 
by colocalization of endoglin and Ki67 immunofluorescence staining (Fig. 4C). It is well 
known that marked hyperplasia is an early event seen after topical application of TPA 
(Argyris, 1982). The comparison of epidermal thickness in vehicle-treated and TPA-treated 
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animals revealed that the hyperplastic response was strongly inhibited in Eng+/- with 
respect to Eng+/+ mice (Fig. 5A, B), as expected because of the restrained proliferative 
capacity of keratinocytes in endoglin-deficient animals (Fig. 5C).        
 
DISCUSSION  
 
 Endoglin plays crucial functions in angiogenesis and inflammation (Bernabéu et al., 
2007; ten Dijke et al., 2008; López-Novoa and Bernabéu, 2010), two processes intimately 
linked to wound healing (Valluru et al., 2011a). In this work, we show that skin wound 
healing is delayed in endoglin-deficient mice, in particular at 2-6 days after the injury. In 
normal mice, endoglin expression is enhanced promptly in keratinocytes and blood vessels 
of wounded skin (Fig. 1). A rapid increase in endoglin expression was previously reported 
in proliferating endothelial cells and infiltrating inflammatory cells in skin punch biopsies 
from human volunteers (Torsney et al., 2002). Elevated endoglin expression was also 
observed in blood vessels in surgical wounds at 3 days post-surgery, suggesting a role for 
endoglin in human cutaneous repair and scar formation (Valluru et al., 2011b). We show in 
this report that the lower rate of healing observed in Endoglin heterozygous mice is 
associated with: i, impaired keratinocyte proliferation at the wound edges; ii, delayed 
granulation tissue formation; and iii, decreased NO bioavailability. Interestingly, elevating 
the expression of endoglin in the wounds of Eng+/- mice by topical application of its cDNA 
restored the rate of healing to normal values (Fig. 2), demonstrating a direct involvement of 
endoglin in wound repair.  
 We have previously reported the expression of endoglin in epidermal keratinocytes 
from the proliferative basal layer, hair bulbs and sebaceous glands (Quintanilla et al., 
2003). Carcinogenesis experiments carried out in Eng+/- mice suggested a crucial function 
of endoglin in epidermal homeostasis by attenuating TGF- signaling in order to allow 
keratinocyte proliferation (Quintanilla et al., 2003; Pérez-Gómez et al., 2005). Therefore, 
the burst of endoglin expression in keratinocytes immediately after wounding appears to be 
related to the wave of epidermal hyperproliferation occurring in the epidermis adjacent to 
the wound to replenish the wounded area with new cells. In endoglin-deficient mice, the 
lack of a hyperproliferative epithelium at the wound edges is evident, as shown by 
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histological and Ki67 immunostaining analyses (Figs. 3 and 4). A close relationship 
between endoglin and epidermal proliferation was confirmed by analyzing the skin of 
Eng+/- and Eng+/+ mice following a single topical application of TPA. As occurred in 
wounded skin, TPA stimulated the expression of endoglin in the basal layer of normal 
epidermis and this enhancement was associated with hyperproliferation, as seen by Ki67 
staining (Fig. 6). Both endoglin expression and the strong epidermal hyperplasia induced 
by TPA in normal mice were attenuated in endoglin heterozygous mice (Fig. 7). 
Interestingly, the epidermis of mutant mice contained a larger subpopulation of 
keratinocytes migrating into the wounded area than that of wild type mice, as suggested by 
its elongated morphology and K17 staining (Fig. 5). These results are compatible with in 
vitro studies showing that the knockdown of endoglin in transformed keratinocytes 
constitutively activates TGF- signaling simultaneously leading to growth arrest and 
increased migration (Pérez-Gómez et al., 2007). In fact, TGF-1, which is released in large 
amounts from platelets immediately after wounding (Assoian et al., 1983), promotes 
keratinocyte migration and re-epithelialization during wound healing (reviewed in Werner 
and Grose, 2003). Also, TGF-3 has been found to regulate epidermal cell migration 
(Bandyopadhyay et al., 2006). 
 Several reports point to an important role of NO in wound healing (reviewed in 
Schwentker et al., 2002; Witte and Warbul, 2002). Thus, clinical studies have revealed that 
oral administration of the NO donor L-arginine has a beneficial effect on wound healing 
(Barbul et al., 1990; Kirk et al., 1993). Both the constitutive, endothelial (eNOS) and 
neuronal (nNOS), and inducible (iNOS) NO synthases are expressed during wound healing, 
and several reports have shown that either reduced activity or expression of NOS leading to 
decreased NO production has a detrimental effect on wound healing (Schaffer et al., 1996; 
Yamasaki et al., 1998; Lee et al., 1999). We and others have reported decreased NO 
production in Eng+/- mice caused by reduced eNOS expression (Jerkic et al., 2004) or 
activity due to the uncoupling of the enzyme with the chaperone Hsp90 leading to 
superoxide production (Toporsian et al., 2005). In this work, we show that delayed wound 
closure in endoglin-deficient mice is also associated with diminished NO availability, as 
increasing NO production in endoglin-deficient mice by oral administration of a NO donor 
accelerated the rate of healing, whereas inhibition of NO synthesis in normal mice 
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significantly delayed wound healing (Fig. 2). Deficient NO synthesis in the wounds of 
endoglin mutant mice may result in a dramatic loss of the keratinocyte proliferative 
capacity (Stallmeyer et al., 1999; Frank et al., 1999) as well as impaired keratinocyte 
production of VEGF and chemotactic cytokines (Frank et al., 1999; Frank et al., 2000; 
Wetzler et al., 2000). Therefore, angiogenesis may also be affected, as endothelial cells 
isolated from endoglin-deficient mice show reduced proliferation, migration and capillary 
tube formation associated with decreased eNOS activity and VEGF secretion (Jerkic et al., 
2006a). Endoglin regulates angiogenesis by modulating TGF- signaling through the type I 
activin-like kinase receptors ALK1 and ALK5 (reviewed in Lebrin and Mummery, 2008).  
Whereas there are conflicting results about the precise roles of these receptors in 
angiogenesis, it is clear that Endoglin heterozygous mice exhibit a reduced angiogenic 
response in vivo (Jerkic et al., 2006b; Düwell et al., 2006), suggesting that endoglin 
haploinsufficiency during wound healing leads to inhibition of the angiogenic switch likely 
by disturbed TGF- signaling. 
A schematic model depicting the effects of endoglin haploinsufficiency on TGF- 
signaling and NO production is presented in Fig. 8. A normal level of endoglin expression 
during wound healing favors angiogenesis and keratinocyte proliferation by modulating NO 
synthesis and TGF- signaling in the endothelial and epidermal compartments (Fig. 8A). 
Endoglin haploinsufficiency in mutant mice leads to defective angiogenesis in the 
endothelial compartment due to disturbed TGF- signaling, whereas, in the epidermis, 
reduced endoglin expression allows increased TGF- signaling which, in turn, results in 
decreased proliferation and increased keratinocyte migration (Fig. 8B). 
It should be noted that, in addition to be involved in wound-healing, Eng is 
overexpressed in several skin pathologies, including escleroderma (Leask et al., 2002; 
Maring et al., 2012; Morris et al., 2011), psoriasis (Rulo et al., 1995; van de Kerkhof et al., 
1998), and in the irradiated skin (Wang et al., 1993). All these data support the relevance of 
endoglin in skin function and disease. 
 
MATERIALS AND METHODS 
 
Animals  
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Generation and genotyping of Eng+/– mice on a C57Bl/6 background was previously 
described (Bourdeau et al., 1999; Rodríguez-Peña et al., 2002). Mice were kept in 
ventilated rooms. Lighting and temperature were controlled by a timer that permitted light 
between 08:00 and 20:00 h and a temperature of 20 ± 1 ºC. Mice were fed with standard 
mouse chow (Panlab, Madrid, Spain) and water ad libitum. All studies were performed in 
parallel in Eng+/– and Eng+/+ littermate female mice of 4-6 months of age (20 - 25 g). All 
animal procedures were in accordance with the guidelines for animal use published by 
Conseil de l´Europe (No. L358/1-358/6, 1986), Spanish Government (BOE No. 67, pp. 
8509-8512, 1988, and BOE No. 256, pp. 31349-31362, 1990) and were approved by the 
University of Salamanca Animal Care and Use Committee.  
 
Wounding procedure and wound closure analysis  
Mice were anesthetized with isoflurane (starting with 2-3% and maintained with 
1%; Forane®, Abbot). Two full thickness wounds (5 mm in diameter, 5 mm apart) were 
made on the back of the animals by excising the skin and the underlying panniculus 
carnosus. Every two days after wounding, mice were anesthetized with isoflurane and 
wounds borders were drawn on a transparent film. Wound areas (in mm2) were calculated 
from wound perimeter tracings by photographic analysis using SCION IMAGE software 
(Scion Corporation). The original area of each wound (day 0) was given a value of 100 and 
the wounded area on subsequent days was expressed as a percentage of the original area. 
To assess the rate of healing, we calculated the time at which wounds were closed by 50% 
(half closing time; HCT). 
 
Skin endoglin gene delivery  
 The endoglin gene was delivered into the wounded skin as a plasmid. The pCMV-
EndoL vector encoding the human L-endoglin isoform driven by the cytomegalovirus 
promoter was constructed by inserting the 2.3-kb EcoRI endoglin cDNA, obtained by 
digestion of pcEXV-EndoL, into the EcoRI digested pCMV vector (Invitrogen), as 
previously described (Letamendia et al., 1998). Skin transfection with the pCMV-EndoL 
vector (h-end transfection) containing the human L-endoglin or the empty pCMV plasmid 
(mock-transfection) was performed by mixing the plasmids with a glycerol-based galenic 
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cream. The cream was applied onto the injured area of groups of 11 mice daily until the full 
closure of the wounds.  
  
Local NO donor administration and NO synthesis blockade 
To inhibit NO synthesis in vivo, L-NAME (Nw-Nitro-L-Arginine Methyl Ester; 
Sigma) was applied at a dose of 10 mg/Kg/day in the drinking water of groups of 11 Eng+/- 
and Eng+/+ mice until the full wound closure. The same procedure was used to dispense the 
nitrosothiol NO donor LA-803 (30 mg/Kg/day), kindly provided by Lacer SA, Barcelona, 
Spain (García Criado et al., 2009). 
 
Acute TPA treatment 
  A single dose of 12-O-tetradecanoylphorbol-13-acetate (TPA, 12.5 g) or the 
corresponding vehicle (200 L of acetone) was applied onto the shaved dorsal skin of 
groups of Eng+/+ and Eng+/- mice. Animals were sacrificed at 24 h or 48 h of treatment and 
skin was collected. Samples were divided into portions that were either fixed in 
formaldehyde (for immunofluorescence, immunohistochemistry and hematoxylin-eosin 
staining) or snap-frozen (for protein and RNA extraction). Frozen samples were stored at -
80ºC until analysis.  
 
Western blot analysis 
For Western blot analysis skin samples were homogenized in lysis buffer (1% 
Triton X-100, 20 mM Tris/HCl, pH 8.0, 137 mM NaCl, 10% glycerol, 5 mM EDTA, 1 mM 
phenylmethylsulfonyl fluoride, 1 μg/mL aprotinin, 1 μg/mL leupeptin) and lysates cleared 
by centrifugation at 14,000 g. Aliquots of 50 g of total lysate protein were separated by 
SDS-gel electrophoresis and electrotransferred to PVDF membranes. For detection of 
endoglin, -tubulin and -actin, the monoclonal antibodies (mAbs) MJ7/18 (Ge and 
Butcher, 1994), sc-8035 (Santa Cruz Biotechnology) and AC-15 (Sigma-Aldrich), 
respectively, were used followed by appropriate secondary Abs coupled to horseradish 
peroxidase. The peroxidase activity was developed using an enhanced chemiluminescence 
kit (Amersham Biosciences, Barcelona, Spain). 
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Quantitative reverse transcription-PCR 
Quantitative RT-PCR analysis was carried out as previously described (Pérez-
Gómez et al., 2007). The gene encoding mouse glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was used as an internal control of the RNA quality and amplification. Primers 
for mouse endoglin were: 5’-ACAAGGGGTGAGGTGACGTT-3’; 5’-
GAAACGAGGACCAGGAACAC-3’, and for GAPDH: 5’-
TAATGAGCTGGTCATCCGTG-3’; 5’-CAGGCTTCCCTGAGTTCATC-3’. The 
annealing temperatures were 56ºC and 55ºC, respectively.  
 
Histology, immunohistochemistry and immunofluorescence analyses 
Skin biopsy specimens were obtained at different days after injury. At each time 
point, an area which included the scab and the complete epithelial margin was excised from 
each individual wound. As a control, a similar area of skin was taken from the back of 
unwounded mice. For histological analysis, dissected wounds were fixed in 4% buffered 
formaldehyde for 24 hours followed by dehydration through a graded ethanol series and 
embedded in paraffin. Sections of 3 μm thick were cut, mounted on glass slides and 
processed. One set of slides were rinsed with water, counterstained with hematoxylin-eosin 
(H&E), washed in water, dehydrated and mounted with a coverslip using Tissue-Tek (Miles 
Inc). Other sets of slides were subsequently incubated for 1 h at room temperature using 
antibodies recognizing mouse endoglin or Ki67 (KI67) (1:25 diluted in PBS, 0.1% bovine 
serum albumin; Santa Cruz). The slides were stained with the avidin-biotinperoxidase 
complex system from Santa Cruz using 3-amino-9-ethylcarbazole as a chromogenic 
substrate and mounted with a coverslip using Tissue-Tek (Miles Inc.). For 
inmunohistochemical Keratin 17 detection, epitope retrieval was performed in a steamer 
during 3 min in 10 mM sodium citrate buffer (pH 6.0) and staining with -Keratin 17 Ab-1 
(Labvision). Inmunodetection was performed using the LSAB method (DAKO) with DAB as 
the chromogen. 
Quantification of epidermal hyperplasia in skin treated with TPA or vehicle was 
performed in H&E-stained sections of Eng+/+ (n=6) and Eng+/- (n=6) littermates in 5 
different fields each. 
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For immunofluorescence analysis in skin treated with TPA, paraffin-embedded 
sections were fixed in 3.7% formaldehyde and subjected to heat-induced antigen retrieval 9 
minutes in Tris-EDTA buffer (10 mM Tris Base, 1 mM EDTA, pH 9.0) prior to exposure to 
primary antibodies. The mAb MJ7/18 recognizing mouse endoglin (Ge and Butcher, 1994) 
and anti-Ki67 from Neomarkers/Lab Vision, (Fremont, California) were used. Secondary 
anti-rat and anti-rabbit Alexa Fluor 594 and Alexa Fluor 488 antibodies were from 
Invitrogen. Cell nuclei were stained with DAPI from Invitrogen (Carlsbad, California). 
Fluorescence confocal images were acquired by using Leica TCS-SP2 software (Wetzlar, 
Germany). Quantification of Ki67-positive nuclei was performed in 5 different fields x 3 
mice each condition. 
 
Statistical analysis  
Between-group comparisons were performed by ANOVA and corrected for 
repeated measures when appropriate. If ANOVA revealed overall significant differences, 
individual means were evaluated post hoc using the Bonferroni procedure. Results are 
expressed as the mean ± SEM. 
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FIGURE LEGENDS 
  
 
Figure 1. Wound healing is delayed in endoglin-deficient mice. (A) Wound closure 
kinetics in normal and mutant mice untreated or treated with liposomes containing the 
endoglin cDNA (ENG). (B) Wound closure kinetics in normal and mutant mice before and 
after oral administration of the inhibitor of NO synthesis L-NAME. (C)  Wound closure 
kinetics in normal and mutant mice before and after oral administration of the NO donor 
LA-803. Data are shown as mean ± SEM (n = 11). *p<0.01 vs Eng+/+; &p<0.01 vs Eng+/-. 
(D) The half closing time (HCT) of the wounds for the different treatments was determined. 
Data are shown as mean ± SEM. #p<0.01 vs Eng+/+ without treatment; &p<0.01 vs Eng+/- 
without treatment. 
 
Figure 2. Re-epithelialization is defective in endoglin-deficient mice. Representative 
histological appearances of wounds in wild-type (A, C) and endoglin-deficient (B, D) mice 
4 days (A, B) and 12 days (C, D) after wounding. Arrows in panels A and B indicate re-
epithelialized wound edges. Re-epithelialization appears to be less efficient in mutant 
compared to control mice. S, scab; P, panniculus carnosus; G, granulation tissue. Scale bar, 
210 μm.  
 
Figure 3. Reduced keratinocyte proliferation in the wounded epidermis of endoglin-
deficient mice. Representative Ki67 immunostaining (brown-stained nuclei in the 
epidermis) in unwounded (A, B) and wounded skin 6 days (C, D) and 12 days (E, F) after 
the injury of normal (A, C, E) and mutant (B, D, F) mice. Limits of regenerating skin in the 
wound are marked with red arrows. Scale bar, 210 μm.  
 
 
Figure 4. TPA stimulates endoglin expression in the epidermis associated with 
hyperproliferation. Normal and mutant mice were subjected to a single topical application 
of TPA or vehicle (acetone), and the expression of endoglin was determined 48 h after the 
treatment. (A) Transcriptional expression of endoglin determined by real time quantitative 
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PCR. Normalized endoglin transcripts were measured relative to GAPDH. Data are 
expressed as the mean + SEM from triplicate determinations.**p<0.01 vs Eng+/+. (B) 
Western blot analysis of endoglin protein expression. β-actin was used as a control for 
protein loading. (C) Representative immunofluorescence analysis of endoglin and Ki67 
expression in the interfollicular epidermis of a wild-type mouse. Nuclei were stained with 
DAPI. Note the strong co-localization of endoglin and Ki67 in basal-like keratinocytes.  
 
Figure 5. Mutant mice exhibit reduced hyperplasia in response to TPA. (A) Representative 
histological appearances of the skin of a normal and mutant mouse 24 h after a single 
topical application of TPA (or vehicle). Sections were counterstained with H&E. Note the 
clear hyperplasia induced in normal skin. (B, C) Quantification of epidermal thickness and 
the proportion of Ki67-positive keratinocytes 24 h after TPA (or vehicle) stimulation. 
**p<0.01 vs TPA-treated Eng+/+ mice. 
 
Figure 6. Schematic model representing the effects of endoglin haploinsufficiency on the 
endothelial and epidermal cell compartments during wound healing. In endothelial cells, 
endoglin deficiency results in reduced NO synthesis and disturbed TGF- signaling that 
impairs the angiogenic response. In the epidermal compartment, reduction of NO synthesis 
and constitutive activation of TGF- signaling as a consequence of endoglin 
haploinsufficiency result in the inhibition of keratinocyte proliferation and stimulation of 
migration.  
 
 






